Literature DB >> 2177205

Action of chlormethiazole in a model of ethanol withdrawal.

A R Green1, E M Davies, H J Little, M A Whittington, A J Cross.   

Abstract

Mice withdrawn from exposure for 14 days to ethanol inhalation showed the expected signs of ethanol withdrawal including convulsive behaviour. Injection of chlormethiazole (100 mg/kg) 5 h after the start of withdrawal, at the time that the convulsive behaviour was near maximal, resulted in the virtual disappearance of the withdrawal-induced behaviour within 30 min, with its reappearance by 60 min. A dose of chlormethiazole of 40 mg/kg was without effect. The time course of the effect of chlormethiazole (100 mg/kg) in the withdrawal test was similar to its effect in raising seizure threshold and decreasing locomotor activity. Chlormethiazole did not alter in vitro binding of [3H]-PN 200-110 to the dihydropyridine sensitive Ca2+ channel. Chlormethiazole, a drug used clinically to treat ethanol withdrawal, has therefore been shown to be effective in this animal model of withdrawal. Dihydropyridine calcium antagonists are also active in the model but chlormethiazole is likely to work by a different mechanism and it is suggested that this may be by increasing GABAergic function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177205     DOI: 10.1007/BF02245928

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  The bioavailability and pharmacodynamics of chlormethiazole in healthy young and elderly volunteers: preliminary findings.

Authors:  K G Jostell; D Fagan; M Björk; F Broberg; R M Mitchell; D B Scott; B Ulff
Journal:  Acta Psychiatr Scand Suppl       Date:  1986

2.  Effect of ethanol on the binding of 35S-T-butylbicyclophosphorothionate to mouse brain membranes.

Authors:  S Liljequist; S Culp; B Tabakoff
Journal:  Life Sci       Date:  1986-05-26       Impact factor: 5.037

3.  A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors.

Authors:  G H Bone; E Majchrowicz; P R Martin; M Linnoila; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex.

Authors:  E J Moody; P Skolnick
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

5.  The modulation by chlormethiazole of the GABAA-receptor complex in rat brain.

Authors:  A J Cross; J M Stirling; T N Robinson; D M Bowen; P T Francis; A R Green
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

6.  Studies on the post-ictal rise in seizure threshold.

Authors:  D J Nutt; P J Cowen; A R Green
Journal:  Eur J Pharmacol       Date:  1981-05-08       Impact factor: 4.432

7.  The effects of acute and chronic ethanol administration and its withdrawal on gamma-aminobutyric acid receptor binding in rat brain.

Authors:  M K Ticku
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

8.  Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms.

Authors:  A K Burroughs; M Y Morgan; S Sherlock
Journal:  Alcohol Alcohol       Date:  1985       Impact factor: 2.826

9.  Is clonidine useful in the treatment of alcohol withdrawal?

Authors:  B J Robinson; G M Robinson; T J Maling; R H Johnson
Journal:  Alcohol Clin Exp Res       Date:  1989-02       Impact factor: 3.455

10.  Chlormethiazole--mode of action.

Authors:  S O Ogren
Journal:  Acta Psychiatr Scand Suppl       Date:  1986
View more
  6 in total

1.  Update on the neurobiology of alcohol withdrawal seizures.

Authors:  Michael A Rogawski
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

3.  Changes in intrinsic inhibition in isolated hippocampal slices during ethanol withdrawal; lack of correlation with withdrawal hyperexcitability.

Authors:  M A Whittington; H J Little; J D Lambert
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

4.  Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.

Authors:  M Rabbani; J Wright; A R Butterworth; Q Zhou; H J Little
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

5.  Effects of diltiazem in convulsive states differ from those previously reported for dihydropyridine calcium channel antagonists.

Authors:  W P Watson; H J Little
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

6.  The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.

Authors:  W P Watson; A Misra; A J Cross; A R Green; H J Little
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.